Strains of Neisseria gonorrhoeae were used to evaluate bactericidal and opsonic properties of McAb 10 directed against the Neisserial outer membrane antigen, H.8. Gonococci were either serum resistant in the absence but serum sensitive in the presence, of McAb 10, or serum sensitive or serum resistant regardless of the presence of McAb 10. Strain JS3, which fell in the former category, was used in subsequent studies. C1 zymogen formed by reassociation of isolated C1 subunits was not directly activated by JS3 in the presence or absence of Cl-inhibitor. JS3 thus was unable to directly activate the classical pathway independently of antibody.
Introduction
Serum bactericidal activity against Neisseria gonorrhoeae is primarily associated with classical complement pathway activation (1) (2) (3) (4) (5) . Although an antibody requirement for lytic activity of serum against clinical isolates of N. gonorrhoeae has been suggested, this presumption has not been rigorously tested.
Selected mutants of gram-negative enteric organisms directly activate the classical complement pathway in vitro in the absence ofantibody (6) (7) (8) (9) . The initiating event is conversion of zymogen Cl to its active serine esterase form (reviewed in references 10 and I 1) upon interaction ofCl with constituents of the bacterial outer membrane. This activation is not abrogated by the serum glycoprotein, Cl -inhibitor, if Cl interacts with rough bacteria containing (truncated) LPS, but the reaction is totally inhibited on the surface of organisms bearing smooth (complete) LpS (6, 9) . N. gonorrhoeae contains LPS bearing only a limited number of core sugar residues (12, 13) , suggesting that this organism may directly activate Cl even in the presence of C 1-inhibitor.
This issue has been examined to a limited extent with gonococci during incubation in serum. Harriman and colleagues (14) showed activation of purified, radiolabeled Cl s in serum during incubation with various serum-sensitive and -resistant gonococci. Shafer and co-workers (4) showed C1 consumption from agammaglobulinemic serum by a serumsensitive mutant of N. gonorrhoeae with "deep rough" LPS. Nonetheless, no studies have been done with N. gonorrhoeae using purified complement components to exclude definitively the contribution of antibody to the observed results. Two issues thus remain unsettled: whether complement is activated in the absence of antibody and, if so, whether activation takes place in the presence of C 1-inhibitor.
Recently, H.8 antigen, common to N. gonorrhoeae and Neisseria meningitidis, has been defined based on its reactivity with several independently derived MAb (15) (16) (17) (18) . H.8 is interesting for several reasons: (a) it has a common, antigenically invariant epitope that is immunoaccessible on viable bacteria in vitro and in vivo (16, (19) (20) (21) ; (b) the antigen (15, 16) and the gene (22) appear to be restricted to the pathogenic (and opportunistic) members of the genus; (c) the H.8 antigen gene contains a repetitive 15-bp sequence constituting > 90% of the structural gene (23) , six copies of which are found in another virulence-associated gene, the azurin gene (24, 25); and (d) H.8 appears to be a lipoprotein, the first described in Neisseria species, and may be important in membrane architecture and integrity. Finally, the H.8 antigen is immunogenic in humans: H.8-specific antibody responses have been detected in patients with local and disseminated gonococcal and meningococcal disease (26, 27) . The contribution of H.8-specific antibody to serum opsonic and bactericidal activity'against N. gonorrhoeae is, therefore, of interest.
In this report, we studied bactericidal and opsonic activities of McAb 10, directed against the H.8 antigen. Our results indicate that McAb 10 is bactericidal for some but not all strains of gonococci during incubation in adsorbed normal human serum. We also show that the serum-resistant clinical isolate JS3 does not directly activate C1, C4, C2, and C3 independently of antibody, but rather accepts C3b deposition resulting from spontaneous, autocatalytic activation of C 1. We demonstrate that C 1-inhibitor blocks autoactivation, and that McAb 10 induces activation of Cl which is not abrogated by Cl-inhibitor, thereby enhancing phagocytosis and killing of gonococci by PMN. These experiments are the first to examine rigorously the contribution of antibody to complement activation by N. gonorrhoeae and to examine the opsonic and bactericidal function of an H.8-reactive MAb.
Methods
Buffers and reagents. HBSS containing 1 mM MgCl2 and 0.15 mM CaC12 (HBSS++)' was the standard buffer in these experiments. In some cases, 0.1% gelatin (Sigma Chemical Co., St. Louis, MO) or 1% BSA (immunoglobulinand fatty acid-free, Boehringer Mannheim Biochemicals, Indianapolis, IN) was added to HBSS+ + (HBSS++GEL; HBSS++ALB). All reagents were brought to room temperature before use.
Serum. Pooled normal human serum (PNHS) was obtained from five normal volunteers with no history of previous gonococcal infections. Serum was adsorbed twice against homologous glutaraldehydefixed N. gonorrhoeae to remove natural antibody, as previously described (28) . Serum adsorbed by this procedure lost < 25% of hemolytic C3 activity measured as described (29) . Aliquots were stored at -700C.
Bacteria. Gonococcal strains used in these experiments are listed in Table I . All strains were tested in the serum bactericidal assays; JS3 was studied in all experiments.
Bacteria were grown on gonococcal agar base (National Institutes of Health Media Room) with 1% Isoyitalex (Becton Dickinson & Co., Inc., Cockeysville, MD) in candle extinction jars at 370C. Transparent, nonpiliated colonies were passed daily. Colony phenotype was determined using the criteria ofSwanson (30) . For experiments, the bacteria were grown 18-20 h, then suspended in HBSS++GEL or HBSS++ALB at room temperature to a concentration of 1 X 108 bacteria/ml (OD600 = 0.100 nm).
MAb. MAb 10 directed against Neisserial surface antigen H.8 was prepared as described by Hitchcock et al. (16) . Tissue culture supernatant was concentrated 20-fold using a 100-ml cell and PM100 membrane (Amicon Corp., Danvers, MA). A second sample was prepared by growing the monoclone in defined medium containing [35S]methionine from New England Nuclear, Boston, MA. The culture supernatant fluid was replaced with fresh medium to which 300 MuCi of [35S]L-methionine was added. The culture was incubated at 37°C in an atmosphere of 10% CO2 for 48 h. The cell-free supernatant fluid-containing the intrinsically labeled McAb 10 was harvested and used undiluted in experiments in which antibody binding was measured.
Complement components. Guinea pig Cl (GPCI; 10,000 U/ml) was purchased from Cordis Laboratories, Miami, FL. Human C I subunits Clq, CIr, and Cls were purified using the methods of Tenner et al. (31) , Ziccardi and Cooper (32) , and Valet and Cooper (33) , respectively. 5 lA Clq (2.7 mg/ml), 34 Ml CIr (187.5 Mg/ml), and 8 Ml Cls (806 Mgg/ml) were mixed on ice in 200 ,l of 1% ultrapure BSA in distilled water, 100 ,l of0.05 M CaCl2, and 815 Ml HBSS++GEL. The mixture was incubated at 30°C for 15 min with shaking to allow association of Cl subunits. This mixture (150 Mul/tube) was used in the assays to achieve a final concentration of complement components equivalent to 5% normal serum concentration. Functionally active human C3 and C4 were purified using the procedure of Hammer et al. (34) , with minor modifications. C3 was radiolabeled with 125I ('251C3) using lodobeads from Pierce Chemical Co., Rockford, IL. Cl-inhibitor was isolated according to previously published methods (35) . Human C2 was prepared by a new procedure using polyethylene glycol precipitation, C4b/iC4b Sepharose, and DEAE Sepharose (Pharmacia Fine 1. Abbreviations used in this paper: GPC1, guinea pig Cl; HBSS++, HBSS containing 1 mM MgCl2 and 0.15 mM CaCl2. Chemicals, Piscataway, NJ) (36) . All proteins were biochemically pure as assessed by SDS-PAGE and immunoelectrophoresis except C4, which contained small amounts of minor contaminants, but was functionally pure for C4 hemolytic activity.
Neutrophils. Neutrophils were obtained from normal volunteers with no history of gonococcal infection and who were not taking antibiotics. Lymphocyte Separation Media from Litton Bionetics, Inc.
(Charleston, SC) was layered under heparinized blood diluted vol/vol with PBS, then centrifuged for 20 min at 1,200 rpm at 20'C. Plasma, platelet, and mononuclear cell supernatant was discarded. Neutrophils were sedimented with 3% dextran 500 from Pharmacia Fine Chemicals in PBS, pH 7.4, for 30 min at 220C. Leukocyte-rich supernatant fluid was centrifuged at 1,500 rpm at 4VC. Contaminating erythrocytes were lysed with cold 0.2% NaCl and physiological ionic strength restored by addition of an equal volume of 1.6% NaCl. After the final centrifugation, the neutrophils were resuspended in HBSS++ALB at a concentration of 5 X 106/ml. Serum bactericidal assay. Bacteria were suspended in HBSS++ALB to QD16w = 0.100 as described above. For presensitization, 100 Ml of this suspension was mixed with 50 Ml of dilutions of McAb 10 in buffer, 50 Ml ofan irrelevant MAb or 50 Ml ofbuffer alone, and the suspension was incubated for 20 min at 22°C with intermittent agitation. Then 100 Ml of this mixture containing presensitized organisms was added to 100 Ml of 20% adsorbed PNHS in HBSS++ALB, and the suspension was incubated at 37°C for 60 min. Viable bacteria were enumerated as CFU by making serial dilutions in' buffer and plating aliquots on chocolate agar plates (National Institutes of Health Media Room) for growth in candle jars at 37°C for 36-48 h. Control samples were handled identically except that presensitized organisms were mixed with 20% adsorbed PNHS previously heated at 56°C for 30 min to block complement activation. Log10 kill was calculated for organisms presensitized with McAb 10 or with buffer as previously described (5) . Binding of 35S-labeled McAb 10 to JS3. Binding of McAb 10 to strain JS3 was examined in a quantitative binding assay. Tissue culture supernatant fluids, unlabeled and 35S-intrinsically labeled, were mixed in HBSS++GEL. The mixture contained 200 Ml 35S McAb 10 and increasing amounts of unlabeled McAb 10 ranging from 0 to 320 Ml. Gonococci, strain JS3 (1 X 106 in 100 Ml HBSS++GEL), were added, and the mixture incubated at 37°C, tumbling for 1 h. Bacteria were then washed twice with HBSS++GEL. After'the final centrifugation, the bacterial pellet was solubilized in 500 Ml of 1% SDS by heating at 100°C for 10 min. Samples were then added to scintillation fluid from Hydrofluor; National Diagnostics, Somerville, NJ, and bacteria-associated radioactivity was counted in a liquid scintillation analyzer (2000CA Tri-Carb; Packard Instrument Co., United Technologies, Downers Grove, IL). Results are expressed as counts per minute bound with each concentration of unlabeled McAb 10.
Activation of C1 by JS3. We next examined whether JS3 directly activated Cl' in the absence of antibody. Deposition of radiolabeled CIs within Cl was measured on JS3 in the presence or absence of Cl-inhibitor. Clq (8 pug), Clr (4.5'Mg), and Cls (4.03 Mg unlabeled and 0.47 Mg '25I labeled) were mixed at 0°C with 15 Ml veronal buffer, 0.05 M CaC12 (final concentration 2.5 mM Ca2+), and 48 Ml H20 containing 1 mg/ml ovalbumin from Sigma Chemical Co. Cl-inhibitor (13.5 Mg) was added to the above mixture before aliquots were mixed with JS3 (1 X 107, 5 X 10', and 1 X 108 organisms). Positive control tubes contained instead of JS3, heat-aggregated human IgG (63°C, 15 min, 1.16 mg/ml) or E. coli J5 (5 X 107 and 1 X 108 organisms), both of which directly activate Cl in the presence or absence of Cl-inhibitor (6, 7, (37) (38) (39) . Negative control tubes contained Cl activator components only in the absence of Cl-inhibitor. These mixtures were incubated at 30°C for 10 min, and the reaction stopped by addition of SDS-urea-DTT (40) . Samples were heated to 37°C for 45 min and SDS-PAGE (8%) and autoradiography were performed. Classical (12.5 ,ug) were added to JS3 and the mixture incubated at 30C for 15 min with shaking. The mixtures were centrifuged at 12,500 g (Eppendorf centrifuge) for 5 min and the supernatant fluid was discarded. Then classical complement components were added as unlabeled C3 (11.96 ,g), '251I-C3 (7. 82 Ag), C4 (6,000 U), and C2 (0.8 Mg), the final volume was brought to 1 ml with HBSS++GEL, and the mixture tumbled for 15 min at 37°C. Triplicate 200-Ml aliquots were transferred to microcentrifuge tubes containing 1 ml cold HBSS++GEL and centrifuged at 12,500 g for 10 min at 4°C. After discarding the supernatant, the sides of the tube were washed with 500
Ml HBSS++GEL, and the pellet was centrifuged again, the supernatant discarded, and the pellet was counted in a gamma scintillation counter from Packard Multi-Prias, Packard Instrument Co. The bacterial pellet was solubilized in SDS sample buffer (41) containing 2% mercaptoethanol for 10 min at 100°C, then frozen at -70°C for subsequent examination by SDS-PAGE.
Form ofC3 bound to JS3. The molecular form of 1251I-C3 deposited on the gonococcal surface with purified classical pathway components was examined. Solubilized samples from the C3 binding experiment were divided in two equal aliquots. To cleave covalent ester linkages between C3 and acceptor molecules, one aliquot was mixed with 4M' 200 mM methylamine in carbonate buffer at pH 11 and incubated at 37°C for 1 h. Then 1.4 Ml of0.5 N HCl was added to achieve a final pH 7.8. Aliquots of methylamineand nonmethylamine-treated samples were applied to a 7.5% SDS polyacrylamide gel and electrophoresis was performed (41) . Autoradiography was done on dried gels.
Killing ofJ53 by PMN. Strain JS3 was presensitized with McAb 10 and/or classical complement pathway components exactly as described above in C3 binding assays. Gonococci (1 X 107 organisms in 100 Ml HBSS++ALB) bearing complement components, McAb 10, or both, were mixed with 2.5 X 106 PMN in 500 Mil HBSS++ALB or HBSS++GEL (JS3/PMN = 4:1) in microcentrifuge tubes. The volume was brought to 1 ml with HBSS++ALB, and the mixture was tumbled at 12 rpm at 37°C. Samples were removed at 0, 15, 30, and 60 min, diluted serially in HBSS++GEL or HBSS++ALB, and duplicate 50-Ml aliquots of each dilution were plated on chocolate agar. CFU were counted on each plate after incubation for 16-20 h in candle jars at 37°C. Results at each time period are expressed as percent of the time zero inoculum.
Results
Bactericidal activity of McAb 10. All the gonococcal strains characterized in Table I were tested for susceptibility to the bactericidal activity of adsorbed PNHS, alone or with added McAb 10 (Table II) . The strains fell into three categories: (a) strains FA 635 and 7189 were sensitive to killing in adsorbed serum, and killing increased slightly with McAb 10 presensitization; (b) strains RI 1, FA 638, WG, 7220, 7221, and 6305 were resistant to killing in the presence or absence of McAb 10; and (c) strains JS3 and 7122 were serum resistant in the absence of McAb 10, but were serum sensitive when presensitized with McAb 10. In subsequent studies we used strain JS3 because of its differential susceptibility to serum killing in the presence and absence of McAb 10 and because JS3 has been well characterized with respect to outer membrane constituents (42-44). Specific binding ofMcAb 10 to JS3. Experiments were designed to estimate the amount of McAb 10 binding to JS3. Increasing amounts of unlabeled McAb 10 were mixed with a constant amount of 35S-labeled McAb 10 in buffer before gonococci were added. After 60 min at 370C, the organisms were washed and bacteria-associated radioactivity was counted. Results were expressed (Fig. 1) as counts per minute bound at each concentration of added unlabeled antibody. Characteristic of specific binding, as increasing amounts of unlabeled McAb 10 were added, less radioactivity became associated with JS3, reflecting competitive inhibition of [35S]-McAb 10 by unlabeled McAb 10. Furthermore, these results indicate that in the above experiment and in all experiments reported below using 20-50-gl volumes of McAb 10 to sensitize JS3 at 1 X 108/ml, the amounts of antibody bound are below saturating levels.
Activation of C1 by JS3. Cl zymogen was prepared by mixing Clq, Clr, and radiolabeled C ls at 00C, with or without Cl -inhibitor, before adding to Cl activators or JS3 for incubation at 30'C. No concentration ofJS3 tested in the presence or absence ofC 1-inhibitor activated Cl as determined by absence Classical complement pathway activation by JS3. We then tested whether JS3 would activate purified components of the classical pathway (C1, C4, C2, and C3) in the presence of McAb 10. Strain JS3, with or without McAb 10 presensitization, was mixed with GPC1 or reassociated human Cl subunits, followed by 5% serum levels of C4, C2, and C3 plus 125i-C3 or, in control experiments, 5% serum levels of C4 and C3 plus '251-C3. Classical complement pathway activation was determined by measuring binding of '251-C3 to JS3 after a 30-min incubation at 370C. Specific binding of '251-C3 to JS3 occurred in the absence of added McAb 1O, whether GPC1 or human Cl was used (Fig. 2) . The extent of specific binding (molecules bound with C1423 minus molecules bound with C 143) was 4,000 molecules C3/organism with GPC 1 and 3,000 molecules/organism with human Cl. When JS3 was presensitized with McAb 10, specific binding of C3 remained -4,500 molecules ofC3/organism, regardless of the source of C l. Irrelevant MAb neither blocked nor enhanced C3 binding (not shown). Because antibody-independent activation of Cl by JS3 was excluded earlier, the C3 deposition observed in the absence of McAb 10 can only be explained by the activation state of the Cl used in these experiments. GPCI is available only in activated form and is capable of activating the remaining human classical pathway components. Human Cl zymogen subjected to the conditions of this assay (379C for 30 min) spontaneously activates by the autocatajytic mechanism (37). In agreement with this model, when Cl (GPC I or human C 1) and Cl-inhibitor (both at 5% normal serum concentrations) were added to gonococci before addition of C4, C2, and C3, deposition of C3 was completely abrogated (Fig. 3 ). Similar results were obtained when Cl-inhibitor was added together with C4, C2, and C3 (not shown). Experiments were then done was also prevented by Cl -inhibitor. JS3 pretreated with McAb 10 was incubated with a mixture of human Cl and Cl-inhibitor, followed by C4, C2, and C3. McAb 10 completely restored Cl activation and C3 binding by JS3 ( Fig. 3 ).
Form of C3 bound to JS3. We analyzed the form of C3 deposited on JS3 with purified classical pathway components using SDS-PAGE and autoradiography. In the absence of methylamine (Fig. 4, left) , C3-acceptor complexes migrating at 150,000 mol wt and larger were observed, as well as a large amount of a (120,000), a' (110,000) chain, and A chain (75,000) of C3b. The autoradiogram shown does not clearly demonstrate distinct a and a' bands, but both fragments are apparent in less heavily exposed autoradiograms. No such high molecular weight C3-acceptor complexes were noted in lanes containing samples lacking C2. This reinforced earlier results showing no specific binding of C3 unless all classical components were present. Upon treatment with methylamine ( Fig. 4, right), C3 was released from acceptor molecules and migrated as C3b in the form of C3a' and C3,3 chains (110,000 and 75,000 mol wt, respectively). No bands corresponding to the 68,000-mol wt a', fragment of iC3b or the 41,000-mol wt a'2 fragment of C3dg were observed. The experiment shown was performed with GPCI, but was repeated several times using human Cl with the same outcome (not shown). These results indicate that a portion of C3 deposited with purified classical pathway components binds covalently as a portion of C3b to Significant killing in comparison to buffer was noted for all combinations of opsonins tested (Table III) focused on the interaction of the gonococcal surface with antibody (McAb 10) directed against the H.8 antigen and with classical pathway components. We have reported in this paper that McAb 10 has differential bactericidal activity for various strains of gonococci in adsorbed PNHS. We next showed antibody-independent C3b deposition on strain JS3 gonococci via the classical complement pathway. Although addition of Clinhibitor blocked this activation, McAb 10 fully restored classical pathway activation and enhanced PMN phagocytosis and killing of gonococci. We have thus demonstrated, using a system of rigorously controlled, purified complement constituents, that antibody is necessary for classical pathway activation in the presence of Cl-inhibitor by a clinical, serum-resistant isolate of N. gonorrhoeae. Complement activation is regulated in serum (and plasma) by Cl-inhibitor. In the absence of this inhibitor, Cl can spontaneously autoactivate (reviewed in references 9 and 37-39). Cl-inhibitor does not prevent Cl activation mediated by soluble immune complexes or by antibody-coated erythrocytes. A role for both antibody and for C4 in protecting activated Cl against inactivation by Cl-inhibitor has been suggested (45) .
A variety of substances and particles have been shown to activate Cl in the presence of C 1-inhibitor, but in the absence of antibody (46) (47) (48) (49) (50) Serum-resistant gonococci activate the classical pathway in non-immune or adsorbed human serum. Although C3 and C5b-9 are deposited on the bacterial outer membrane, killing does not occur (14, 28) . Bactericidal rabbit polyclonal antibody alters the site of deposition or molecular configuration of C5b-9 bound to the gonococcal surface without increasing the amount of bound C5b-9 (28, 53) . Similar results are reported for bactericidal human antibody for N. gonorrhoeae (53) as well as for some, but not all, murine MAb directed against the major gonococcal outer membrane protein PI (5) . Such a change in form or site of binding of C5b-9 to some serum-resistant organisms is the most likely explanation for killing of serum-resistant JS3 by adsorbed PNHS supplemented with McAb 10.
The specific antibody, MAblO, enhanced neutrophil phagocytosis and killing of JS3. In the absence of serum, neutrophils avidly ingest piliated gonococci containing some but not all PII proteins (55, 56) . In contrast, nonpiliated organisms lacking PII are not ingested in the absence of opsonization (55, 56) . A rigorous dissection of the relative contribution of antibody and complement to phagocytosis of N. gonorrhoeae has not previously been attempted with purified opsonins. Our data suggest that both anti-H. 8 IgG and C3b facilitate phagocytosis of JS3 by neutrophils, but that optimal phagocytosis is achieved with a combination of both ligands.
